N-(5-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-1,3,4-oxadiazol-2-yl)-2-phenylquinoline-4-carboxamide结构式
|
常用名 | N-(5-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-1,3,4-oxadiazol-2-yl)-2-phenylquinoline-4-carboxamide | 英文名 | N-(5-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-1,3,4-oxadiazol-2-yl)-2-phenylquinoline-4-carboxamide |
|---|---|---|---|---|
| CAS号 | 851094-57-0 | 分子量 | 450.4 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C26H18N4O4 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 英文名 | N-(5-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-1,3,4-oxadiazol-2-yl)-2-phenylquinoline-4-carboxamide |
|---|
| 分子式 | C26H18N4O4 |
|---|---|
| 分子量 | 450.4 |
| InChIKey | RFCAALYUIJSGQX-UHFFFAOYSA-N |
| SMILES | C1COC2=C(O1)C=CC(=C2)C3=NN=C(O3)NC(=O)C4=CC(=NC5=CC=CC=C54)C6=CC=CC=C6 |
|
实验名称:WHO-TDR: Human African Trypanosomiasis (HAT)
来源:ChEMBL
靶标:Trypanosoma brucei brucei
External Id:CHEMBL2093839
|